Ganirelix Acetate

Indicated for topical treatment of mild to moderate atopic dermatitis in adult and pediatric patients 3 months of age and older.

Indicated for the treatment of chorea associated with Huntington’s disease, tardive dyskinesia in adults.

Indicated for the treatment of adult patients with locally advanced or metastatic urothelial carcinoma (mUC), that has susceptible FGFR3 or FGFR2 genetic alterations, and progressed during or following at least one line of prior platinum-containing chemotherapy, including within 12 months of neoadjuva...

Iindicated for the treatment of secondary hyperparathyroidism (HPT) in adult patients with chronic kidney disease (CKD) on hemodialysis.

Indicated for Prophylaxis of Organ Rejection in Kidney Transplantation and Prophylaxis of Organ Rejection in Liver Transplantation

Indicated for the treatment of Hormone receptor (HR)-positive, human epidermal growth factor receptor 2 (HER2)-negative advanced breast cancer in postmenopausal women not previously treated with endocrine therapy, or HR-positive advanced breast cancer in postmenopausal women with disease progression...

Indicated in combination with lenalidomide and dexamethasone for the treatment of patients with multiple myeloma who have received at least one prior therapy.

Indicated for the long-term treatment of acromegalic patients who have had an inadequate response to surgery and/or radiotherapy, or for whom surgery and/or radiotherapy is not an option.

Indicated in combination with an aromatase inhibitor for the treatment of pre/perimenopausal or postmenopausal women, with hormone receptor (HR)-positive, human epidermal growth factor receptor 2 (HER2)-negative advanced or metastatic breast cancer, as initial endocrine-based therapy; or fulvestrant ...

Indicated in the palliative treatment of advanced prostatic cancer.

Indicated in adults for the treatment of irritable bowel syndrome with constipation (IBS-C), chronic idiopathic constipation (CIC)

Indicated as an adjunct to diet and exercise to improve glycemic control in patients 10 years and older with type 2   diabetes mellitus,  to reduce the risk of major adverse cardiovascular events (cardiovascular death, non-fatal myocardial   infarction, or non-fat...